Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News GlaxoSmithKline announces board changes

GlaxoSmithKline announces board changes

3rd January 2006

GlaxoSmithKline (GSK) has announced that from the beginning of this year there will be two new non-executive directors on its board.

Dr Ralph Horwitz, dean of the School of Medicine at Western Reserve University, Ohio, and Tom de Swaan currently Chief Financial Officer and member of the management board of ABN AMRO, will be joining the board.

It was also announced that Dr Lucy Shapiro will retire as a non-executive director at the company’s annual general meeting on May 17th 2006.

GSK chairman Sir Christopher Gent said: “During the last nine years Lucy has provided the board with invaluable advice and support for which I and my board colleagues are immensely grateful.

“I am delighted that Ralph has agreed to join the board. In addition to fulfilling his usual responsibilities as a non-executive director, he will spend time within our research and development organisation and, with his experience, will provide valuable insights to scientific and clinical developments outside GSK.”

Mr de Swaan is to join the audit committee and will succeed Dr Ronaldo Schmitz as its chairman in September 2006.

Sir Christopher said: “I am very glad that Tom, who has had a long and distinguished career in international banking, has agreed to join the board and take over from Ronaldo as chairman of the audit committee.

“This is a challenging and demanding role that Ronaldo has undertaken with great skill and I am delighted that he has also agreed to remain on the board for a further term of three years.”

track© Adfero Ltd

We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.